US Patent Issued to BIOGEN MA on Sept. 29 for "Compounds for targeting degradation of Bruton's tyrosine kinase" (Massachusetts Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,747,241, issued on Sept. 29, was assigned to BIOGEN MA INC. (Cambridge, Mass.).

"Compounds for targeting degradation of Bruton's tyrosine kinase" was invented by Kevin M. Guckian (Northborough, Mass.), Eric Stefan (Watertown, Mass.), Corey Don Anderson (Brighton, Mass.), Jae Young Ahn (Somerville, Mass.), Morgan Welzel O'Shea (Waltham, Mass.), Jeremy L Yap (Sudbury, Mass.), Xinpeng Cheng (Watertown, Mass.), Brian T. Hopkins (Newton, Mass.), Isaac Marx (Arlington, Mass.) and Marta Nevalainen (Holliston, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to compounds of Formula (A): BTK-L-DSM (A) or a pharmaceutically acceptable...